General Information of Drug Transporter (DT)
DT ID DTD0289 Transporter Info
Gene Name SLC35A3
Transporter Name UDP-N-acetylglucosamine transporter
Gene ID
23443
UniProt ID
Q9Y2D2
Post-Translational Modification of This DT
Overview of SLC35A3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35A3 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Serine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35A3 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

19

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Serine 19 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35A3 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

27

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Serine 27 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC35A3 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Serine 133 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35A3 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

17

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Threonine 17 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35A3 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Threonine 18 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35A3 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

23

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Threonine 23 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35A3 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

7

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Tyrosine 7 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35A3 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

26

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Tyrosine 26 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35A3 [4]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

8

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35A3 Valine 8 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35A3 [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

80

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC35A3 Lysine 80 has the potential to affect its expression or activity.
References
1 Quantitative Proteomics Reveals the Dynamics of Protein Phosphorylation in Human Bronchial Epithelial Cells during Internalization, Phagosomal Escape, and Intracellular Replication of Staphylococcus aureus. J Proteome Res. 2016 Dec 2;15(12):4369-4386.
2 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
3 Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
4 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
5 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.